High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus

Research Communications in Molecular Pathology and Pharmacology

Volumn 92, Issue 1, 1996, Pages 43-52

  Imagawa, Akihisa ^a   Itoh, Naoto ^a   Hanafusa, Toshiaki ^a   Katsura, Hayato ^b   Yamaguchi, Akio ^c   Takeda, Akira ^d   Iwahashi, Hiromi ^a   Nakajima, Hiromu ^a   Miyagawa, Jun Ichiro ^a   Namba, Mitsuyoshi ^a   Kuwajima, Masamichi ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Katsura Clinic   (Japan)

^c SANOFI   (France)

^d MATSUE RED CROSS HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; ISLETS OF LANGERHANS; MALE; RADIOIMMUNOASSAY; TIME FACTORS;

EID: 9344234424     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Atkinson, M.A. and Maclaren, N.K. (1993a). Islet cell autoantigens in insulin-dependent diabetes. J. Clin. Invest. 92: 1608-1616.
2. Atkinson, M.A., Kaufman, D.L., Newman, D., Tobin, A.J., and Maclaren, N.K. (1993b). Islet cell cytoplasmic autoantibody reactivity to glutamic acid decarboxylase in insulin-dependent diabetes. J. Clin. Invest. 91: 350-356.
3. Bottazzo, G.F., and Gleichmann, H. (1986). Immunology and diabetes workshops: report of the first international workshop on the standardization of cytoplasmic islet cell antibodies. Diabetologia 29: 125-126.
4. Eisenbarth, G.S. (1986). Type 1 diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 314: 1360-1368
5. Imagawa, A., Itoh, N., Hanafusa, T., Waguri, M., Kuwajima M., and Matsuzawa, Y. (1996). Antibodies to glutamic acid decarboxylase induced by interferon-alpha therapy for chronic viral hepatitis. Diabetologia 39: 126
6. Itoh, N., Hanafusa, T., Katsura, H., Yamamoto, K., Takeda, A., Kurahashi, A., Nabika, T., Miyazaki, A., Miyagawa, J., Kono, N., and Tarui, S. (1991). Two types of autoantibodies to adrenal medullary cells in Type 1 (insulin-dependent) diabetic patients: Prevalence, properties and implications. J. Autoimmun. 4: 807-18.
7. Kobayashi, T., Sugimoto, T., Itoh, T., Kosaka, K., Tanaka, T., Suwa, S., Sato, K., and Tsuji, K. (1986). The prevalence of islet cell antibodies in Japanese insulin-dependent and non-insulin-dependent diabetic patients studied by indirect immunofluorescence and by a new method. Diabetes 35: 335-40.
8. National Diabetes Data Group (1979). Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057.
9. Rowley, M.J., Mackay, I.R., Chen, Q-Y., Knowles, W.J., and Zimmet, P.Z. (1992). Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 41: 548-551.
10. Schmidli, R.S., Colman, P.O., Bonifacio, E., and participating laboratories. (1995). Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The second international GAD Ab workshop. Diabetes 44: 636-640.
11. Seissler, J., Amann, J., Mauch, L., Haubruck, H., Wolfahrt, S., Bieg, S., Richter, W., Holl, R., Heinze, E., Northemann, W., and Scherbaum, W. A. (1993). Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 92: 1394-1399.
12. Shall, S.C., Malone, J.I., and Simpson, N.E. (1989). A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. N. Engl. J. Med. 320: 550-554.
13. Takino, H., Kawasaki, E., Yano, M., Matsumoto, K., Uotani, S., Okuno, S., Takao, Y., Yamasaki, H., Yamaguchi, Y., Akazawa, S., and Nagataki, S. (1994). The heterogeneity of whole islet cell cytoplasmic antibodies evidenced by absorption test with glutamic acid decarboxylase. J. Autoimmun. 7: 389-398.
14. The diabetes control and complications trial research group (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986.
15. Tsuruoka, A., Matsuba, I., Toyota, T., Ishiki, G., Nagataki, S. and Ikeda, Y. (1995). Antibodies to GAD in Japanese diabetic patients: a multicenter study. Diabetes. Res. Clin. Pract. 28: 191-199
16. Vives-Pi, M., Somoza, N., Vargas, F., Armengol, P., Sarri, Y., Wu, J.Y., and Pujol-Borrell, R. (1993). Expression of glutamic acid decarboxylase (GAD) in the a, b and d cells of normal and diabetic pancreas: implications for the pathogenesis of type I diabetes. Clin. Exp. Immunol. 92: 391-396.